Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 3:9:867830.
doi: 10.3389/fsurg.2022.867830. eCollection 2022.

Surgical Planning in Penetrating Abdominal Crohn's Disease

Affiliations
Review

Surgical Planning in Penetrating Abdominal Crohn's Disease

Pär Myrelid et al. Front Surg. .

Abstract

Crohn's disease (CD) is increasing globally, and the disease location and behavior are changing toward more colonic as well as inflammatory behavior. Surgery was previously mainly performed due to ileal/ileocaecal location and stricturing behavior, why many anticipate the surgical load to decrease. There are, however, the same time data showing an increasing complexity among patients at the time of surgery with an increasing number of patients with the abdominal perforating disease, induced by the disease itself, at the time of surgery and thus a more complex surgery as well as the post-operative outcome. The other major cause of abdominal penetrating CD is secondary to surgical complications, e.g., anastomotic dehiscence or inadvertent enterotomies. To improve the care for patients with penetrating abdominal CD in general, and in the peri-operative phase in particular, the use of multidisciplinary team discussions is essential. In this study, we will try to give an overview of penetrating abdominal CD today and how this situation may be handled. Proper surgical planning will decrease the risk of surgically induced penetrating disease and improve the outcome when penetrating disease is already established. It is important to evaluate patients prior to surgery and optimize them with enteral nutrition (or parenteral if enteral nutrition is ineffective) and treat abdominal sepsis with drainage and antibiotics.

Keywords: Crohn's disease; complications; optimisation; perforating disease; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Abdominal fistulizing Crohn's disease may develop due to penetrating disease but more often due to surgical complications. With increasing non-responsive attempts with medical therapies (e.g., steroids, immunomodulators, and/or biologicals) patients may develop clinical impairment with an increasing number of surgical risk factors like weight loss, hypo-albuminemia, or penetrating disease. Before deciding on a primary anastomosis or not the risk of anastomotic dehiscence should be evaluated as well as if the patient is fit enough to survive such complication or not. The patient must be fully aware of such risks as there is a risk of severe post-operative morbidity and mortality. In a patient deemed not suitable for surgery with primary anastomosis pre-operative optimization (e.g., enteral or parenteral nutrition, drainage of collections, and antibiotics) may change this and otherwise patients should be advised toward two-stage surgery with two-barrel stoma (of the future anastomosis) or possibly a covering stoma.
Figure 2
Figure 2
Example of pre-operative optimization components.

References

    1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. (2002) 347:417–29. 10.1056/NEJMra020831 - DOI - PubMed
    1. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, et al. . Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. (2006) 101:1274–82. 10.1111/j.1572-0241.2006.00552.x - DOI - PubMed
    1. Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, et al. . Identification of a prodromal period in Crohn's disease but not ulcerative colitis. Am J Gastroenterol. (2000) 95:3458–62. 10.1111/j.1572-0241.2000.03361.x - DOI - PubMed
    1. Hellers G, Bergstrand O, Ewerth S, Holmstrom B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut. (1980) 21:525–7. 10.1136/gut.21.6.525 - DOI - PMC - PubMed
    1. Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, et al. . The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. (2002) 122:875–80. 10.1053/gast.2002.32362 - DOI - PubMed